Pasar al contenido principal

CARACTERIZACION DE LOS MECANISMOS DE RESISTENCIA ADQUIRIDOS POR TRANSFERENCIA LATERAL DE GENES DURANTE LA TERAPIA FAGICA

PID2020-117708GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Host-pathogen interaction, Enterobacter cloacae exerts different adhesion and invasion capacities against different host cell types

  • Frutos Grilo, Elisabet|||0000-0001-5092-5675
  • Kreling, Vanessa
  • Hensel, Andreas|||0000-0003-0886-8384
  • Campoy Sánchez, Susana|||0000-0003-1369-0197
New antibiotics are urgently needed due to the huge increase of multidrug-resistant bacteria. The underexplored gram-negative bacterium Enterobacter cloacae is known to cause severe urinary tract and lung infections (UTIs). The pathogenicity of E. cloacae in UTI has only been studied at the bioinformatic level, but until now not within systematic in vitro investigations. The present study assesses different human cell lines for monitoring the early steps of host-pathogen interaction regarding bacterial adhesion to and invasion into different host cells by flow cytometric adhesion assay, classical cell counting assay, gentamicin invasion assay, and confocal laser scanning microscopy. To our knowledge, this is the first report in which E. cloacae has been investigated for its interaction with human bladder, kidney, skin, and lung cell lines under in vitro conditions. Data indicate that E. cloacae exerts strong adhesion to urinary tract (bladder and kidney) and lung cells, a finding which correlates with the clinical relevance of the bacterium for induction of urinary tract and lung infections. Furthermore, E. cloacae ATCC 13047 barely adheres to skin cells (A-431) and shows no relevant interaction with intestinal cells (Caco-2, HT-29), even in the presence of mucin (HT29 MTX). In contrast, invasion assays and confocal laser scanning microscopy demonstrate that E. cloacae internalizes in all tested host cells, but to a different extent. Especially, bladder and kidney cells are being invaded to the highest extent. Defective mutants of fimH and fimA abolished the adhesion of E. cloacae to T24 cells, while csgA deletion had no influence on adhesion. These results indicate that E. cloacae has different pattern for adhesion and invasion depending on the target tissue, which again correlates with the clinical relevance of the pathogen. For detailed investigation of the early host-pathogen interaction T24 bladder cells comprise a suitable assay system for evaluation the bacterial adhesion and invasion.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of mutagenesis and lateral gene transfer processes in bacterial susceptibility to phage in food biocontrol and phage therapy

  • López-Pérez, Júlia
  • Otero Carrera, Jennifer|||0000-0003-0175-5520
  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Erill, Ivan|||0000-0002-7280-7191
  • Cortés Garmendia, M. Pilar|||0000-0002-5924-0653
  • Llagostera Casas, Montserrat|||0000-0001-8177-8321
The emergence of resistance and interference mechanisms to phage infection can hinder the success of bacteriophage-based applications, but the significance of these mechanisms in phage therapy has not been determined. This work studies the emergence of Salmonella isolates with reduced susceptibility to a cocktail of three phages under three scenarios: i) Salmonella cultures (LAB), ii) biocontrol of cooked ham slices as a model of food safety (FOOD), and iii) oral phage therapy in broilers (PT). S. Typhimurium ATCC 14028 RifR variants with reduced phage susceptibility were isolated from the three scenarios and conventional and molecular microbiology techniques were applied to study them. In LAB, 92% of Salmonella isolates lost susceptibility to all three phages 24 h after phage infection. This percentage was lower in FOOD, with 4.3% of isolates not susceptible to at least two of the three phages after seven days at 4°C following phage treatment. In PT, 9.7% and 3.3 % of isolates from untreated and treated broilers, respectively, displayed some mechanism of interference with the life cycle of some of the phages. In LAB and FOOD scenarios, resistant variants carrying mutations in rfc and rfaJ genes involved in lipopolysaccharide synthesis (phage receptor) were identified. However, in PT, the significant decrease of EOP, ECOI, and burst size observed in isolates was prompted by lateral gene transfer of large IncI1 plasmids, which may encode phage defense mechanisms. These data indicate that the acquisition of specific conjugative plasmids has a stronger impact than mutagenesis on the emergence of reduced phage-susceptibility bacteria in certain environments. In spite of this, neither mechanism seems to significantly impair the success of Salmonella biocontrol and oral phage therapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Reciprocal regulation between Acinetobacter baumannii and Enterobacter cloacae AdeR homologs, implications for antimicrobial resistance and pathogenesis

  • Gaona Soler, Marc
  • Corral, Jordi|||0000-0003-2047-6156
  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Campoy Sánchez, Susana|||0000-0003-1369-0197
  • Barbé García, Jordi|||0000-0003-4408-013X
  • Pérez Varela, María|||0000-0003-0990-4041
  • Aranda Rodríguez, Jesús|||0000-0002-1135-095X
Acinetobacter baumannii and Enterobacter cloacae are phylogenetically distant Gram-negative bacterial pathogens that represent significant challenges in healthcare settings due to their remarkable ability to acquire antimicrobial resistance. This study investigates one of the most important efflux pump systems in A. baumannii, AdeABC-AdeRS, and identifies homologous components in E. cloacae. By constructing isogenic knockout mutants, we show that the AdeB pump component and the AdeR regulator are significant for antimicrobial resistance and pathogenicity in A. baumannii. Through in silico predictions, we identify homologs of AdeB and AdeR (ECL_01758 and ECL_01761, respectively) in E. cloacae. Notably, we demonstrate that while the inactivation of the E. cloacae gene encoding the AdeB protein does not impact on pathogenesis and only alters colistin susceptibility, a knockout mutant of the gene encoding the AdeR regulator significantly affects susceptibility to various antimicrobial classes, motility, and virulence. Additionally, we demonstrate that the AdeR regulators of A. baumannii and E. cloacae can functionally substitute for each other both in vitro and in vivo conditions. Electrophoretic mobility shift assays reveal that these regulators are capable of binding to the promoter regions of each other's species, where similar DNA motifs are present. Furthermore, cross-complementation tests show that the affected phenotypes in each species can be restored interchangeably. Moreover, phylogenomic analysis of previously published E.cloacae genomes and reconstructrion of ancestral states through the phylogenetic trees of the adeB and adeR genes suggest that these homologs are more likely derived from a common ancestor rather than through recent horizontal gene transfer. The findings of this work highlight that conserved regulatory functions concerning efflux pump expression can be maintained across species despite evolutionary divergence and open new perspectives for the control of bacterial infections.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The novel MFS efflux pump SxtP, regulated by the LysR-type transcriptional activator SxtR, is involved in the susceptibility to sulfamethoxazole/trimethoprim (SXT) and the pathogenesis of Acinetobacter baumannii

  • Gaona Soler, Marc
  • Corral, Jordi|||0000-0003-2047-6156
  • Campoy Sánchez, Susana|||0000-0003-1369-0197
  • Barbé García, Jordi|||0000-0003-4408-013X
  • Pérez Varela, María|||0000-0003-0990-4041
  • Aranda Rodríguez, Jesús|||0000-0002-1135-095X
Acinetobacter baumannii is a notorious opportunistic pathogen responsible for healthcare-associated infections worldwide. Efflux pumps play crucial roles in mediating antimicrobial resistance, motility, and virulence. In this study, we present the identification and characterization of the new A. baumannii efflux pump SxtP belonging to the MFS superfamily (major facilitator superfamily), along with its associated activator LysR-type transcriptional regulator (LTTR) SxtR, demonstrating their roles in sulfamethoxazole/trimethoprim (also known as co-trimoxazole or SXT) resistance, surface-associated motility and virulence.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Deciphering the causes of ibfa-mediated abortive infection in the P22-like phage UAB_Phi20

  • Lopez Perez, Julia
  • Cortés Garmendia, M. Pilar|||0000-0002-5924-0653
  • Campoy Sánchez, Susana|||0000-0003-1369-0197
  • Erill, Ivan|||0000-0002-7280-7191
  • Llagostera Casas, Montserrat|||0000-0001-8177-8321
The study of bacterial defense mechanisms against phages is becoming increasingly relevant due to their impact on the effectiveness of phage therapy. Employing a multifaceted approach that combines bioinformatics, molecular microbiology, TEM microscopy, and conventional microbiology techniques, here, we identify the ibfA gene as a novel defense factor targeting the virulent phage UAB_Phi20, acquired by Salmonella Typhimurium through lateral transfer on the IncI1α conjugative plasmid pUA1135 after oral phage therapy in broilers. IbfA, a two-domain protein containing ATPase and TOPRIM domains, significantly reduces UAB_Phi20 productivity, as indicated by decreased EOP, ECOI, and a diminished burst size, potentially reducing cellular viability without causing observable lysis. Our results indicate that IbfA enhances the transcription of early genes, including the antirepressor ant, which inhibits the C2 repressor of the lytic cycle. This may cause an imbalance in Cro/C2 concentration, leading to the observed reduction in the transcription of late genes encoding structural and cellular lysis proteins, and resulting in the abortion of UAB_Phi20 infection.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A novel GntR-ABC efflux system mediates oxidative stress response, drug resistance, motility and virulence in Acinetobacter baumannii ATCC 17978

  • Corral, Jordi|||0000-0003-2047-6156
  • Pérez Varela, María|||0000-0003-0990-4041
  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Gaona Soler, Marc
  • Campoy Sánchez, Susana|||0000-0003-1369-0197
  • Barbé García, Jordi|||0000-0003-4408-013X
  • Aranda Rodríguez, Jesús|||0000-0002-1135-095X
INTRODUCTION: Acinetobacter baumannii is a highly adaptable opportunistic pathogen, notorious for its persistence in healthcare environments and its remarkable ability to withstand oxidative stress, antimicrobial treatments, and immune defenses. METHODS: In this study, we characterized the role of the GntR family transcriptional regulator AUO97_RS16340 and its associated ABC efflux pump (AUO97_RS16355-RS16360-RS16365), previously identified as part of the OxyR regulon. RESULTS: Through gain- and loss-of-function analyses, we demonstrate that this GntR regulator positively regulates the expression of the adjacent ABC efflux pump and plays a critical role in tolerance to H2O2-induced oxidative damage. Furthermore, we show that this efflux system contributes to multiple virulence-associated traits, including antimicrobial resistance, surface-associated motility, and virulence. DISCUSSION: Our findings reveal a new efflux system that links oxidative stress adaptation, efflux-mediated antimicrobial susceptibility, and pathogenicity in A. baumannii strain ATCC 17978. Given the high conservation of the GntR transcriptional regulator and its associated efflux pump across A. baumannii genomes, these components represent promising therapeutic targets. Disrupting their activity could sensitize bacteria to oxidative stress and antimicrobials while attenuating virulence, providing a potential strategy to combat multidrug-resistant A. baumannii.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Limited Emergence of Salmonella enterica Serovar Infantis Variants with Reduced Phage Susceptibility in PhagoVet-Treated Broilers

  • Sevilla-Navarro, Sandra|||0000-0002-2354-9800
  • Otero Carrera, Jennifer|||0000-0003-0175-5520
  • López Pérez, Júlia
  • Torres-Boncompte, Jan|||0000-0002-3431-218X
  • Prucha, Tiago
  • Gussem, Maarten De
  • Silva, Daniela|||0000-0002-2235-4630
  • Burgan, Julia
  • Catalá-Gregori, Pablo|||0000-0002-8298-102X
  • Cortés Garmendia, M. Pilar|||0000-0002-5924-0653
  • Llagostera Casas, Montserrat|||0000-0001-8177-8321
Salmonella enterica serovar Infantis (S. Infantis) poses a growing issue in the poultry sector, with phage-based products emerging as a safe and effective control measure. This study investigated the emergence of reduced-phage-susceptibility variants (RPSV) of S. Infantis in PhagoVet-treated broilers, given that RPSV could undermine phage treatment efficacy. The bacteriophages in the PhagoVet product were characterized using transmission electron microscopy (TEM), genome sequencing, and infection profiling. Furthermore, two broiler trials were conducted: a challenge group (T1) and a challenge-and-treated group (T2). The S. Infantis infective dose was set at 10 4 and 10 6 colony-forming units (CFUs) per animal, with PhagoVet administration at 10 6 and 10 8 plaque-forming units (PFUs) per animal, in Trials 1 and 2, respectively. The results revealed that the four PhagoVet bacteriophages belonged to different genera. PhagoVet evidenced broad-spectrum efficacy against 271 strains representing 18 Salmonella serovars. In Trial 1, PhagoVet reduced bacterial counts in feces to nearly undetectable levels by day 42, with no RPSV detected. However, in Trial 2, three and five RPSVs were detected in feces and ceca, respectively. Consequently, PhagoVet demonstrated efficacy against S. Infantis in broilers, and the potential impact of RPSV is deemed unlikely to compromise its efficacy.